Patents by Inventor Zhengfan Jiang

Zhengfan Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220193125
    Abstract: An immune enhancement composition and a vaccine composition comprising newly precipitated manganese and/or colloid manganese, a preparation method therefor, and use thereof for immunization and/or vaccination enhancement.
    Type: Application
    Filed: April 20, 2020
    Publication date: June 23, 2022
    Applicant: PEKING UNIVERSITY
    Inventors: Zhengfan JIANG, Chenguang WANG, Rui ZHANG, Mengze LV
  • Publication number: 20110214194
    Abstract: Compositions and methods are provided for screening and identifying compounds which modulate signaling of toll-like receptor 4 (TLR4) pathway via CD 14 and a ligand. Methods are provided for treatment of various disease states such as inflammation or autoimmune disease in mammalian subjects by modulating toll-like receptor 4 (TLR4) pathway signaling via CD 14 and a ligand. Transgenic non-human animals and methods for developing transgenic non-human animals are provided wherein the transgenic non-human animals comprise a loss-of-function mutation in the CD 14 gene.
    Type: Application
    Filed: May 5, 2006
    Publication date: September 1, 2011
    Inventors: Bruce Beutler, Zhengfan Jiang
  • Publication number: 20070231335
    Abstract: Compositions and methods are provided for treating Gram positive bacterial infection in a mammalian subject. Compositions and methods are further provided for treating Gram positive bacterial skin infection in the mammalian subject. Compositions and methods are provided that comprise administering to the mammalian subject an effective amount of a compound that activates Scd1 gene expression or activates Scd1 gene product.
    Type: Application
    Filed: July 19, 2006
    Publication date: October 4, 2007
    Inventors: Bruce Beutler, Phillipe Georgel, Zhengfan Jiang
  • Publication number: 20060257411
    Abstract: Compositions and methods are provided for screening and identifying compounds which modulate signaling of toll-like receptor 4 (TLR4) pathway via CD14 and a ligand. Methods are provided for treatment of various disease states such as inflammation or autoimmune disease in mammalian subjects by modulating toll-like receptor 4 (TLR4) pathway signaling via CD14 and a ligand. Transgenic non-human animals and methods for developing transgenic non-human animals are provided wherein the transgenic non-human animals comprise a loss-of-function mutation in the CD14 gene.
    Type: Application
    Filed: May 4, 2006
    Publication date: November 16, 2006
    Inventors: Bruce Beutler, Zhengfan Jiang